<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="https://hdl.handle.net/10259/4863">
<title>Artículos OHM</title>
<link>https://hdl.handle.net/10259/4863</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="https://hdl.handle.net/10259/11586"/>
<rdf:li rdf:resource="https://hdl.handle.net/10259/11321"/>
<rdf:li rdf:resource="https://hdl.handle.net/10259/11295"/>
<rdf:li rdf:resource="https://hdl.handle.net/10259/10928"/>
</rdf:Seq>
</items>
<dc:date>2026-05-12T19:23:27Z</dc:date>
</channel>
<item rdf:about="https://hdl.handle.net/10259/11586">
<title>An Efficient, Organic Solvent-Free Method for Extraction and Concentration of Hepatitis E Virus from Pig Liver</title>
<link>https://hdl.handle.net/10259/11586</link>
<description>An Efficient, Organic Solvent-Free Method for Extraction and Concentration of Hepatitis E Virus from Pig Liver
Santamaría Palacios, Jorge; García, Nerea; Rodríguez Lázaro, David
The presence of the hepatitis E virus (HEV) in pork products, particularly in pig liver has been frequently described. However, a standardized method is not still available for the detection of HEV in foods, particularly in those difficult food matrixes such as pig meat and pork products. The aim of this study was to design, optimize and evaluate a new method of food-separation and virus concentration for HEV in pig liver samples. This method is based on organic flocculation and avoids the use of organic solvents. The virus recovery rates and analytical sensitivity of the method using murine norovirus MNV-1 as a surrogate were 73.6–82.2% and at least 1 × 103 TCID50 per g of liver in 100% of the replicates, respectively. Furthermore, this new methodology was validated by testing the presence of HEV RNA in naturally infected pig liver samples, comparing it with two other commonly used concentration methods. The new extraction method run satisfactory in comparison with the two reference methods; statistically equivalent (p &lt; 0.05) to one of the methods used while presented statistically significant better results (p &lt; 0.05) compared to the second method. Consequently, our results indicate that the new extraction method can be an adequate cost-effective and ecologically friendly alternative for the food separation and concentration of HEV RNA in pig liver samples.
</description>
<dc:date>2025-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="https://hdl.handle.net/10259/11321">
<title>Identification of PimR as a Positive Regulator of Pimaricin Biosynthesis in            Streptomyces natalensis</title>
<link>https://hdl.handle.net/10259/11321</link>
<description>Identification of PimR as a Positive Regulator of Pimaricin Biosynthesis in            Streptomyces natalensis
Antón Fidalgo, Nuria; Mendes, Marta V.; Martín, Juan F.; Aparicio, Jesús F.
Sequencing of the DNA region on the left fringe of the pimaricin gene cluster revealed the presence of a 3.6-kb gene, pimR, whose deduced product (1,198 amino acid residues) was found to have amino acid sequence homology with bacterial regulatory proteins. Database comparisons revealed that PimR represents the archetype of a new class of regulators, combining a Streptomyces antibiotic regulatory protein (SARP)-like N-terminal section with a C-terminal half homologous to guanylate cyclases and large ATP-binding regulators of the LuxR family. Gene replacement of pimR from Streptomyces natalensis chromosome results in a complete loss of pimaricin production, suggesting that PimR is a positive regulator of pimaricin biosynthesis. Gene expression analysis by reverse transcriptase PCR (RT-PCR) of the pimaricin gene cluster revealed that S. natalensis ΔPimR shows no expression at all of the cholesterol oxidase-encoding gene pimE, and very low level transcription of the remaining genes of the cluster except for the mutant pimR gene, thus demonstrating that this regulator activates the transcription of all the genes belonging to the pimaricin gene cluster but not its own transcription.
</description>
<dc:date>2004-05-01T00:00:00Z</dc:date>
</item>
<item rdf:about="https://hdl.handle.net/10259/11295">
<title>Red blood cells derived from peripheral blood and bone marrow CD34+ human haematopoietic stem cells are permissive to Plasmodium parasites infection</title>
<link>https://hdl.handle.net/10259/11295</link>
<description>Red blood cells derived from peripheral blood and bone marrow CD34+ human haematopoietic stem cells are permissive to Plasmodium parasites infection
Fernandez Becerra, Carmen; Lelievre, Joel; Ferrer, Mireia; Antón Fidalgo, Nuria; Thomson, Richard; Peligero, Cristina; Almela, Maria Jesus; Lacerda, Marcus VG; Herreros, Esperanza; del Portillo, Hernando A
The production of fully functional human red cells in vitro from haematopoietic stem cells (hHSCs) has been successfully achieved. Recently, the use of hHSCs from cord blood represented a major improvement to develop the continuous culture system for Plasmodium vivax. Here, we demonstrated that CD34+ hHSCs from peripheral blood and bone marrow can be expanded and differentiated to reticulocytes using a novel stromal cell. Moreover, these reticulocytes and mature red blood cells express surface markers for entrance of malaria parasites contain adult haemoglobin and are also permissive to invasion by P. vivax and Plasmodium falciparum parasites.
</description>
<dc:date>2013-09-01T00:00:00Z</dc:date>
</item>
<item rdf:about="https://hdl.handle.net/10259/10928">
<title>Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice</title>
<link>https://hdl.handle.net/10259/10928</link>
<description>Broadly Cross-Reactive, Nonneutralizing Antibodies against Influenza B Virus Hemagglutinin Demonstrate Effector Function-Dependent Protection against Lethal Viral Challenge in Mice
Arunkumar, Guha Asthagiri; Ioannou, Andriani; Wohlbold, Teddy John; Meade, Philip; Aslam, Sadaf; Amanat, Fatima; Ayllón Barasoain, Juan; García Sastre, Adolfo; Krammer, Florian
Protection from influenza virus infection is canonically associated with antibodies that neutralize the virus by blocking the interaction between the viral hemagglutinin and host cell receptors. However, protection can also be conferred by other mechanisms, including antibody-mediated effector functions. Here, we report the characterization of 22 broadly cross-reactive, nonneutralizing antibodies specific for influenza B virus hemagglutinin. The majority of these antibodies recognized influenza B viruses isolated over the period of 73 years and bind the conserved stalk domain of the hemagglutinin. A proportion of the characterized antibodies protected mice from both morbidity and mortality after challenge with a lethal dose of influenza B virus. Activity in an antibody-dependent cell-mediated cytotoxicity reporter assay correlated strongly with protection, suggesting that Fc-dependent effector function determines protective efficacy. The information regarding mechanism of action and epitope location stemming from our characterization of these antibodies will inform the design of urgently needed vaccines that could induce broad protection against influenza B viruses.
</description>
<dc:date>2019-03-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
